Europe
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Pfizer and BioNTech indicate that this data, along with preclinical data and additional data being generated, will be leveraged to choose a dose level and pick the best vaccine candidate out of the several being evaluated.
Bavencio is an anti-PD-L1 checkpoint inhibitor co-developed by Merck KGaA, Darmstadt, German and Pfizer via EMD Serono, a business unit of the two companies.
Amidst the pandemic, the biopharma industry continues to surge ahead. Jobs look plentiful. Check out these companies that have made recent job announcement expansions.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 1, 2020.
Researchers have found that the strains spreading so quickly in Europe and the U.S. have a mutated S “spike” protein that makes it about 10 times more infectious than the strain that originally was identified in Asia.
This was on top of Syncona’s previously announced Series C investment in Freeline of $40 million, with another $80 million in new capital.
Clinical-stage biotechnology company BioNTech announced a private investment of $250 million today, led by Temasek and other investors.
Salt water gargle is a time-tested way to alleviate sore-throat pain. It can help clear stuffy sinuses. But, is it effective against the symptoms of COVID-19?
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 29, 2020.
PRESS RELEASES